Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGL

Angle (AGL)

Angle Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGL
DateTimeSourceHeadlineSymbolCompany
01/29/202510:26AMAlliance NewsAlliance NewsAngle reports breakthrough in dual cancer DNA analysisLSE:AGLAngle Plc
01/29/20251:00AMRNS Regulatory NewsAngle PLC Analysis of CTC-DNA and ctDNA using Illumina assayLSE:AGLAngle Plc
01/24/20254:05AMRNS Non-RegulatoryAngle PLC Parsortix used in research paper from ETH ZurichLSE:AGLAngle Plc
01/23/20258:22AMAlliance NewsAlliance NewsAngle fails to win market confidence despite narrowing loss in 2024LSE:AGLAngle Plc
01/23/20251:00AMRNS Regulatory NewsAngle PLC Trading UpdateLSE:AGLAngle Plc
12/13/20242:43AMRNS Non-RegulatoryAngle PLC HER2 presentation at SABCSLSE:AGLAngle Plc
11/15/20248:33AMAlliance NewsAlliance NewsAngle stock surges as firm showcases new assay productsLSE:AGLAngle Plc
11/15/20241:00AMRNS Non-RegulatoryAngle PLC Parsortix based PD-L1 assay showcased at AACRLSE:AGLAngle Plc
11/15/20241:00AMRNS Non-RegulatoryAngle PLC Research on HER2 assay kit showcased at AACRLSE:AGLAngle Plc
11/13/20241:00AMRNS Non-RegulatoryAngle PLC ANGLE presents two posters at EACRLSE:AGLAngle Plc
11/11/20246:07AMAlliance NewsAlliance NewsAngle notes use of Parsortix system in treatment resistance studyLSE:AGLAngle Plc
11/11/20241:00AMRNS Non-RegulatoryAngle PLC Parsortix enriched CTC & ctDNA in NSCLC patientsLSE:AGLAngle Plc
10/17/20241:00AMRNS Non-RegulatoryAngle PLC Publication demonstrates CTC profiling potentialLSE:AGLAngle Plc
09/26/20247:30AMAlliance NewsAlliance NewsEARNINGS: Ebiquity bemoans poor conditions on swing to interim lossLSE:AGLAngle Plc
09/26/20241:01AMRNS Non-RegulatoryAngle PLC 100th publication supporting Parsortix system useLSE:AGLAngle Plc
09/26/20241:00AMRNS Regulatory NewsAngle PLC Half-year ReportLSE:AGLAngle Plc
09/23/20241:00AMRNS Regulatory NewsAngle PLC Exclusive agreement for DNA NGS panelLSE:AGLAngle Plc
09/19/20248:44AMAlliance NewsAlliance NewsIN BRIEF: Angle celebrates agreement with Recursion PharmaceuticalsLSE:AGLAngle Plc
09/19/20241:00AMRNS Non-RegulatoryAngle PLC Agreement with Recursion PharmaceuticalsLSE:AGLAngle Plc
09/17/20241:00AMRNS Regulatory NewsAngle PLC Notice of Interim Results and WebcastLSE:AGLAngle Plc
08/23/20245:43AMAlliance NewsAlliance NewsIN BRIEF: Angle hails publication of research data in science journalLSE:AGLAngle Plc
08/22/20241:00AMRNS Non-RegulatoryAngle PLC Data supporting FDA approval published in JournalLSE:AGLAngle Plc
08/01/20241:00AMRNS Non-RegulatoryAngle PLC Independent Parsortix studyLSE:AGLAngle Plc
07/18/20244:08AMRNS Regulatory NewsAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
07/12/20249:38AMRNS Regulatory NewsAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
07/11/20249:07AMRNS Regulatory NewsAngle PLC Result of 2024 Annual General MeetingLSE:AGLAngle Plc
06/21/20244:52AMAlliance NewsAlliance NewsIN BRIEF: Angle says open offer raises proceeds of GBP500,000LSE:AGLAngle Plc
06/21/20241:00AMRNS Regulatory NewsAngle PLC Result of open offerLSE:AGLAngle Plc
06/18/20248:41AMRNS Regulatory NewsAngle PLC Posting of 2023 Annual Report & Notice of the AGMLSE:AGLAngle Plc
06/11/20241:00AMRNS Non-RegulatoryAngle PLC Parsortix and assays being showcased at EACR 2024LSE:AGLAngle Plc
 Showing the most relevant articles for your search:LSE:AGL